Interactions between artemisinins and other antimalarial drugs in relation to the cofactor model--a unifying proposal for drug action (Q41927945)

14 October 2017

Interactions between artemisinins and other antimalarial drugs in relation to the cofactor model--a unifying proposal for drug action (English)

1 reference

14 October 2017

0 references

0 references

Richard K Haynes

1

0 references

Paolo Coghi

12

object named as

Paolo Coghi

1 reference

14 October 2017

Kwan-Wing Cheu

2

1 reference

14 October 2017

Ho-Wai Chan

3

1 reference

14 October 2017

Ho-Ning Wong

4

1 reference

14 October 2017

Ka-Yan Li

5

1 reference

14 October 2017

Maggie Mei-Ki Tang

6

1 reference

14 October 2017

Min-Jiao Chen

7

1 reference

14 October 2017

Zu-Feng Guo

8

1 reference

14 October 2017

Zhi-Hong Guo

9

1 reference

14 October 2017

Kumar Sinniah

10

1 reference

14 October 2017

Amanda B Witte

11

1 reference

14 October 2017

Diego Monti

13

1 reference

14 October 2017

30 October 2012

1 reference

14 October 2017

1 reference

14 October 2017

7

1 reference

14 October 2017

12

1 reference

14 October 2017

2204-2226

1 reference

Facile oxidation of leucomethylene blue and dihydroflavins by artemisinins: relationship with flavoenzyme function and antimalarial mechanism of action

14 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Different behavior of artemisinin and tetraoxane in the oxidative degradation of phospholipid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Oxidants, oxidant drugs, and malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Artemisinin and a Series of Novel Endoperoxide Antimalarials Exert Early Effects on Digestive Vacuole Morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Glutathione reductase of the malarial parasite Plasmodium falciparum: crystal structure and inhibitor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Interactions of methylene blue with human disulfide reductases and their orthologues from Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Dithiol proteins as guardians of the intracellular redox milieu in parasites: old and new drug targets in trypanosomes and malaria-causing plasmodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Reactions of antimalarial peroxides with each of leucomethylene blue and dihydroflavins: flavin reductase and the cofactor model exemplified

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Quantification of singlet oxygen production in the reaction of superoxide with hydrogen peroxide using a selective chemiluminescent probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Characterization of NADPH-dependent methemoglobin reductase as a heme-binding protein present in erythrocytes and liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Flavin reductase: sequence of cDNA from bovine liver and tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

The mechanism and substrate specificity of the NADPH:flavin oxidoreductase from Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Crystal structure of NAD(P)H:flavin oxidoreductase from Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Simulation study of methemoglobin reduction in erythrocytes. Differential contributions of two pathways to tolerance to oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Computational and experimental studies on the catalytic mechanism of biliverdin-IXbeta reductase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Methylene blue as an antimalarial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Neurotoxic mode of action of artemisinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

The role of heme and the mitochondrion in the chemical and molecular mechanisms of mammalian cell death induced by the artemisinin antimalarials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

In vitro activity of Proveblue (methylene blue) on Plasmodium falciparum strains resistant to standard antimalarial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Molecular genetics evidence for the in vivo roles of the two major NADPH-dependent disulfide reductases in the malaria parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

The molecular mechanism of action of artemisinin--the debate continues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Interaction of artemisinins with oxyhemoglobin Hb-FeII, Hb-FeII, carboxyHb-FeII, heme-FeII, and carboxyheme FeII: significance for mode of action and implications for therapy of cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

The Fe2+-mediated decomposition, PfATP6 binding, and antimalarial activities of artemisone and other artemisinins: the unlikelihood of C-centered radicals as bioactive intermediates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Identification of an antimalarial synthetic trioxolane drug development candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Identification of a 1,2,4,5-tetraoxane antimalarial drug-development candidate (RKA 182) with superior properties to the semisynthetic artemisinins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Endoperoxide carbonyl falcipain 2/3 inhibitor hybrids: toward combination chemotherapy of malaria through a single chemical entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

A fragmenting hybrid approach for targeted delivery of multiple therapeutic agents to the malaria parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Second generation analogues of RKA182: synthetic tetraoxanes with outstanding in vitro and in vivo antimalarial activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

The labile iron pool: characterization, measurement, and participation in cellular processes(1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

The role of reactive oxygen and nitrogen species in cellular iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Chemistry for an essential biological process: the reduction of ferric iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Reduced flavins promote oxidative DNA damage in non-respiring Escherichia coli by delivering electrons to intracellular free iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Reduction of Fe(III) ions complexed to physiological ligands by lipoyl dehydrogenase and other flavoenzymes in vitro: implications for an enzymatic reduction of Fe(III) ions of the labile iron pool

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Identification and characterization of heme-interacting proteins in the malaria parasite, Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

The malaria parasite type II NADH:quinone oxidoreductase: an alternative enzyme for an alternative lifestyle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Evidence for a common non-heme chelatable-iron-dependent activation mechanism for semisynthetic and synthetic endoperoxide antimalarial drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

A Partial Convergence in Action of Methylene Blue and Artemisinins: Antagonism with Chloroquine, a Reversal with Verapamil, and an Insight into the Antimalarial Activity of Chloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Piperaquine: a resurgent antimalarial drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Artesunate--amodiaquine combination therapy for falciparum malaria in young Gabonese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Activities of amodiaquine, artesunate, and artesunate-amodiaquine against asexual- and sexual-stage parasites in falciparum malaria in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Optimising operational use of artesunate-mefloquine: a randomised comparison of four treatment regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

An integrated assessment of the clinical safety of artemether-lumefantrine: a new oral fixed-dose combination antimalarial drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Clinical pharmacology of artemisinin-based combination therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

In vitro assessment of methylene blue on chloroquine-sensitive and -resistant Plasmodium falciparum strains reveals synergistic action with artemisinins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Antimalarial drug synergism and antagonism: mechanistic and clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

In vitro interactions between piperaquine, dihydroartemisinin, and other conventional and novel antimalarial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Role of known molecular markers of resistance in the antimalarial potency of piperaquine and dihydroartemisinin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Effects of piperaquine, chloroquine, and amodiaquine on drug uptake and of these in combination with dihydroartemisinin against drug-sensitive and -resistant Plasmodium falciparum strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

In vitro interaction of dihydroartemisin and lumefantrine in clinical field isolates from Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Qinghaosu resistance in rodent malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Artemether-mefloquine combination in multidrug resistant falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

A comparative clinical trial of two different regimens of artemether plus mefloquine in multidrug resistant falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Synergism between mefloquine and artemisinin and its enhancement by retinol in Plasmodium falciparum in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Synergism between arteether and mefloquine or quinine in a multidrug-resistant strain of Plasmodium falciparum in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

The effect of artesunate combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

In vitro activity of riboflavin against the human malaria parasite Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Bioanalytical Screening of Riboflavin Antagonists for Targeted Drug Delivery - A Thermodynamic and Kinetic Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Enhanced uptake and metabolism of riboflavin in erythrocytes infected with Plasmodium falciparum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Plasmodium berghei: implication of intracellular glutathione and its related enzyme in chloroquine resistance in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Glutathione is involved in the antimalarial action of chloroquine and its modulation affects drug sensitivity of human and murine species of Plasmodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Plasmodium falciparum ferredoxin-NADP+ reductase His286 plays a dual role in NADP(H) binding and catalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Plasmodium vivax trophozoites insensitive to chloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Hemoglobin metabolism in the malaria parasite Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Selective enhancement of cellular oxidative stress by chloroquine: implications for the treatment of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Chloroquine mediates specific proteome oxidative damage across the erythrocytic cycle of resistant Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Early transcriptional response to chloroquine of the Plasmodium falciparum antioxidant defence in sensitive and resistant clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

The nature of .pi.-.pi. interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Aggregation of methylene blue in frozen aqueous solutions studied by absorption spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

1H-NMR studies on the self-association of chloroquine in aqueous solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Solvent-induced effects: self-association of positively charged pi systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Interactions between pairs of antimalarial drugs studied by experimental and ab initio (13)C NMR chemical shifts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

The antimalarial drug mefloquine binds to membrane phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

A nuclear magnetic resonance study of the interactions of the antimalarials chloroquine, quinacrine, quinine and mefloquine with lipids extracted from normal human erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

The susceptibility of the malarial parasite Plasmodium falciparum to quinoline-containing drugs is correlated to the lipid composition of the infected erythrocyte membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Interaction of quinine with model lipid membranes of different compositions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Quinine and chloroquine differentially perturb heme monomer-dimer equilibrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Heterologous expression and ATPase activity of mutant versus wild type PfMDR1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Purified Plasmodium falciparum multi-drug resistance protein (PfMDR 1) binds a high affinity chloroquine analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Effects of solvent composition and ionic strength on the interaction of quinoline antimalarials with ferriprotoporphyrin IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Mapping antimalarial pharmacophores as a useful tool for the rapid discovery of drugs effective in vivo: design, construction, characterization, and pharmacology of metaquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Molecular modeling and UV-vis spectroscopic studies on the mechanism of action of reversed chloroquine (RCQ).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Interaction of quinoline antimalarial drugs with ferriprotoporphyrin IX, a solid state spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Soluble synthetic analogues of malaria pigment: structure of mesohematin anhydride and its interaction with chloroquine in solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Recent advances in the discovery of haem-targeting drugs for malaria and schistosomiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Haemozoin (beta-haematin) biomineralization occurs by self-assembly near the lipid/water interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Increase on the initial soluble heme levels in acidic conditions is an important mechanism for spontaneous heme crystallization in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

The crystal structure of halofantrine-ferriprotoporphyrin IX and the mechanism of action of arylmethanol antimalarials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Iron(III) protoporphyrin IX complexes of the antimalarial Cinchona alkaloids quinine and quinidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

The hydroxyl functionality and a rigid proximal N are required for forming a novel non-covalent quinine-heme complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Structure-activity relationships in 4-aminoquinoline antiplasmodials. The role of the group at the 7-position

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Accelerated denaturation of hemoglobin and the antimalarial action of chloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

A verapamil-sensitive chloroquine-associated H+ leak from the digestive vacuole in chloroquine-resistant malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

The antimalarial ferroquine: role of the metal and intramolecular hydrogen bond in activity and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

A novel endogenous antimalarial: Fe(II)-protoporphyrin IX alpha (heme) inhibits hematin polymerization to beta-hematin (malaria pigment) and kills malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Glutathione reductase-catalyzed cascade of redox reactions to bioactivate potent antimalarial 1,4-naphthoquinones--a new strategy to combat malarial parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Artemisinins target the SERCA of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Docking studies of structurally diverse antimalarial drugs targeting PfATP6: no correlation between in silico binding affinity and in vitro antimalarial activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Calcium, ATP, and ROS: a mitochondrial love-hate triangle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

H2O2-induced changes in mitochondrial activity in isolated mouse pancreatic acinar cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Of malaria, metabolism and membrane transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Artemisinins and the biological basis for the PfATP6/SERCA hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

A major genome region underlying artemisinin resistance in malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Cytotoxic interactions of methylene blue with trypanosomatid-specific disulfide reductases and their dithiol products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Artemisinin-resistant malaria: research challenges, opportunities, and public health implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Toward a novel metal-based chemotherapy against tropical diseases. 2. Synthesis and antimalarial activity in vitro and in vivo of new ruthenium- and rhodium-chloroquine complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Comparison of the Reactivity of Antimalarial 1,2,4,5-Tetraoxanes with 1,2,4-Trioxolanes in the Presence of Ferrous Iron Salts, Heme, and Ferrous Iron Salts/Phosphatidylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

Artemisinin enhances heme-catalysed oxidation of lipid membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

7 January 2021

Superoxide does react with peroxides: direct observation of the Haber-Weiss reaction in the gas phase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

7 January 2021

Highly Antimalaria-Active Artemisinin Derivatives: Biological Activity Does Not Correlate with Chemical Reactivity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

7 January 2021

Reply to Comments on ?Highly Antimalaria-Active Artemisinin Derivatives: Biological Activity Does Not Correlate with Chemical Reactivity?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

7 January 2021

Intracellular and extracellular labile iron pools.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

7 January 2021

Bioavailable iron and heme metabolism in Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

7 January 2021

Artemisinin-based combination therapies for uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

7 January 2021

Artemisinin-based combination treatment of falciparum malaria.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

7 January 2021

Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

7 January 2021

Synergism of benflumetol and artemether in Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

7 January 2021

In vitro sensitivity of artemeter in Plasmodium falciparum-infected beta-thalassaemic trait erythrocytes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

7 January 2021

Autoaggregation phenomena in quinine solutions

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200383

7 January 2021

Identifiers

DOI

10.1002/CMDC.201200383

1 reference

release_n7oiinoeirdl5jrok2egqv6amu

14 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/n7oiinoeirdl5jrok2egqv6amu

24 November 2022

mapped directly with Wikidata item

1 reference